Press Release

Worldwide Cardiac Surgical Devices market is valued at 1790 million US$ in 2018 is expected to reach 2340 million US$ by the end of 2025, growing at a CAGR of 3.4% during 2019-2025 | Industry Leaders Covered | Edwards Life Science Corporation, Medtronic Inc., Getinge Group, Atrion Corporation, Abbott Laboratories, Sorin S.P.A., Terumo Medical Corporation, Boston Scientific Corporation, Cook Medical, Angiodynamics, Inc., C. R. Bard, Inc., Trinity Biotech, Abiomed, Inc., Cardinal Health, CyberHeart Incorporated, MedWaves Incorporated, Transmedics, Inc.|

There is a high prevalence of cardiac diseases worldwide, hence an increase in the number of cardiac surgeries. Products such as beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposable are used for cardiac surgery. The key factors that drive the growth of cardiac surgical devices market include rise in incidence […]

Read More